ACT Lung Health Intervention: Phase Two
This study aims to test a counseling and educational program designed to improve lung health through smoking cessation for Chinese and Korean American smokers at high risk for lung cancer.
Checked against the public recordLast updated Mar 13, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Health Services Research
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Dana-Farber Cancer Institute
- Interventions being studied
- Behavioral: ACT Lung Health Intervention
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Self-identify as either Chinese or Korean * Speak either Korean, Mandarin, or English * Are 18 years of age or older * Are current smokers (i.e., have smoked at least 100 traditional cigarettes ever and have smoked at least one traditional cigarette within the prior 30 days) * Will live in the United States for the next 12 months Exclusion Criteria: * Hospitalization due to a serious mental illness (e.g., psychotic disorders) during the prior 6 months. * We will not include any of the following special populations: * Adults unable to consent. * Adults younger than 50 or older than 80 years * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- University of Massachusetts-BostonBoston, Massachusetts
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 13, 2026. Always confirm current availability with the study team.